Cipla reported INR32.66B in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Arca Biopharma USD 6.67M 2.5M Mar/2026
aTyr Pharma USD 3.9M 661K Sep/2026
Bio Path USD 5.16M 260K Mar/2026
Brainstorm Cell Therapeutics USD 7.49M 171K Jun/2026
Capricor Therapeutics 3.05M 31.77K Sep/2026
Cara Therapeutics USD 4.62M 1.4M Mar/2026
Cipla INR 32.66B 361.1M Sep/2026
Dr.Reddys Laboratories INR 32.36B 5.13B Sep/2026
Immunic USD 11.01M 873K Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Nektar Therapeutics USD 10.03M 744K Mar/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sun Pharmaceuticals INR 74.19B 851.6M Sep/2026
TherapeuticsMD USD 143K 4K Jun/2024
UPL INR 140.46B 20.28B Sep/2026